• 2008

Company Description

Biosortia is working on new drugs from deep access to the chemistry of the microbiome for immuno-oncology & immunological therapeutics.

Biosortia has opened the door to a new frontier of fascinating natural products and potential drugs for the treatment of Cancer, CNS and Infectious Diseases by overcoming the challenges of accessing novel high quality bioactive compounds from uncultuable aquatic microorganisms.